MedTrace Logo

Regenerative Surgical Treatment of Peri-implantitis

NCT02500654 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2016-09-01

No results posted yet for this study

Summary

The purpose of the study is to evaluate if surgical treatment of peri-implantitis with enamel matrix derivative (Emdogain®, EMD) will have an additional effect on the healing outcome, changes in the peri-implant microflora and on the inflammatory response in the periimplant pocket at 12 months.

Conditions

Interventions

DEVICE

Emdogain®

Surgery and Emdogain®

DEVICE

Surgery alone

Surgery alone

Sponsors & Collaborators

  • Umeå University

    collaborator OTHER

  • Catrine Isehed

    lead OTHER

Principal Investigators

  • Pernilla Lundberg, Assoc. Prof · Department of Odontology, Division of Molecular Periodontology , Umeå University, Sweden, [email protected]

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02500654 on ClinicalTrials.gov